Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 21762646)

1.

Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.

Kamijo Y, Hashimoto K, Takahashi K, Ehara T, Shigematsu H, Higuchi M.

Clin Nephrol. 2011 Aug;76(2):136-43.

PMID:
21762646
2.

Cyclosporine (CsA) in lupus nephritis: assessing the evidence.

Moroni G, Doria A, Ponticelli C.

Nephrol Dial Transplant. 2009 Jan;24(1):15-20. doi: 10.1093/ndt/gfn565. Epub 2008 Oct 13. Review. No abstract available.

3.

Treatment of lupus nephritis.

Hejaili FF, Moist LM, Clark WF.

Drugs. 2003;63(3):257-74. Review.

PMID:
12534331
4.

Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature.

Hallegua D, Wallace DJ, Metzger AL, Rinaldi RZ, Klinenberg JR.

Lupus. 2000;9(4):241-51. Review.

PMID:
10866094
5.

Lupus nephritis.

Sauter M, Anders HJ.

Minerva Med. 2007 Dec;98(6):749-58. Review.

PMID:
18299686
6.

The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Lee SJ, Silverman E, Bargman JM.

Nat Rev Nephrol. 2011 Oct 18;7(12):718-29. doi: 10.1038/nrneph.2011.150. Review.

PMID:
22009248
7.

Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature.

Seo SR, Lee SJ, Park DJ, Kim TJ, Park YW, Lee SS.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):708-11. Epub 2011 Sep 1. Review.

PMID:
21813067
8.

[Therapeutic effect of retinoic acid in lupus nephritis].

Kinoshita K, Funauchi M.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):1-7. Review. Japanese.

9.

Treatment of systemic lupus erythematosus: a 2012 update.

Merrill JT.

Bull NYU Hosp Jt Dis. 2012;70(3):172-6. Review. No abstract available.

10.

Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.

Yoon KH.

J Biomed Biotechnol. 2010;2010:686480. doi: 10.1155/2010/686480. Epub 2010 Jun 28. Review.

11.

Systemic lupus erythematosus and lupus nephritis.

Koutsokeras T, Healy T.

Nat Rev Drug Discov. 2014 Mar;13(3):173-4. doi: 10.1038/nrd4227. Epub 2014 Feb 14. Review. No abstract available.

PMID:
24525782
12.

Treating lupus in the kidney: where are we now, and where are we going?

Canetta PA, Bomback AS, Radhakrishnan J.

Discov Med. 2011 Oct;12(65):341-9. Review.

13.

[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 7. Cyclosporine].

Yamaji K.

Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2942-7. Review. Japanese. No abstract available.

PMID:
22175135
14.

Diffuse and focal proliferative lupus nephritis: treatment approaches and results.

Pollak VE, Kant KS, Hariharan S.

Nephron. 1991;59(2):177-93. Review. No abstract available.

PMID:
1956480
15.

Proteinuria: abate or applaud abatacept in proteinuric kidney disease?

Reiser J, Alachkar N.

Nat Rev Nephrol. 2014 Mar;10(3):128-30. doi: 10.1038/nrneph.2013.276. Epub 2013 Dec 24. Review.

PMID:
24375054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk